• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 189-203 of 313 results

2030 Exhibit: Exhibit 2030 Simonart 2012

Document IPR2019-00207, No. 2030-61 Exhibit - Exhibit 2030 Simonart 2012 (P.T.A.B. Aug. 9, 2019)
Adjunctive and/or emerging approaches include topical dapsone, taurine bromamine, resveratrol, chemical peels, optical treatments, as well as complementary and alternative medications.
[4,6] The disease burden of acne has the ability to elicit in some sufferers significant mental health concerns due to a heightened sense of shame relating to appearance.
[12,46] Several studies suggest that the efficacy of ben- zoyl peroxide can be enhanced when used in combination with topical retinoids, antibiotics (essentially clindamycin[19,46] and, more recently, nadifloxacin[47]), and tertiary amines, such as an allylamine.
In recent guideline shifts, expert panels and major health organizations have reached a consensus that oral contraceptive provision no longer necessitates the performance of a pelvic examination and Papanicolaou smear.
Am J Clin Dermatol 2012; 13 (6) Simonart A photopneumatic platform (IsolazÔ; Aesthera Corpo- ration, Pleasanton, CA, USA) combining vacuum pressure with a broadband light source device has also been shown to improve mild to moderate inflammatory and comedonal acne.
cite Cite Document
Analyze

2051 Exhibit: Exhibit 2051 FDA Inactive Ingredient Database December 2012

Document IPR2019-00207, No. 2051-82 Exhibit - Exhibit 2051 FDA Inactive Ingredient Database December 2012 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2031 Exhibit: Exhibit 2031 Steiner 2009

Document IPR2019-00207, No. 2031-62 Exhibit - Exhibit 2031 Steiner 2009 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2016 Exhibit: Exhibit 2016 Fleischer et al 2010

Document IPR2019-00207, No. 2016-47 Exhibit - Exhibit 2016 Fleischer et al 2010 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2033 Exhibit: Exhibit 2033 Strauss et al 2007

Document IPR2019-00207, No. 2033-64 Exhibit - Exhibit 2033 Strauss et al 2007 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2040 Exhibit: Exhibit 2040 PDR 2012 Duac

Document IPR2019-00207, No. 2040-71 Exhibit - Exhibit 2040 PDR 2012 Duac (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2053 Exhibit: Exhibit 2053 Osborne 2007 US20070122435A1

Document IPR2019-00207, No. 2053-84 Exhibit - Exhibit 2053 Osborne 2007 US20070122435A1 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2067 Exhibit: Exhibit 2067 Manual of Policies and Procedures Center for Drug Eval...

Document IPR2019-00207, No. 2067-139 Exhibit - Exhibit 2067 Manual of Policies and Procedures Center for Drug Evaluation and Research served August 30, 2019 (P.T.A.B. Dec. 20, 2019)

cite Cite Document
Analyze

2069 Exhibit: Exhibit 2069 Transcript of Deposition of Elaine S Gilmore, MD, PhD, d...

Document IPR2019-00207, No. 2069-141 Exhibit - Exhibit 2069 Transcript of Deposition of Elaine S Gilmore, MD, PhD, dated December 12, 2019 (P.T.A.B. Dec. 20, 2019)

cite Cite Document
Analyze

1053 Exhibit: Sullivan et al 2014

Document IPR2019-00207, No. 1053-114 Exhibit - Sullivan et al 2014 (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1066 Exhibit: Kircik DFD 2015

Document IPR2019-00207, No. 1066-124 Exhibit - Kircik DFD 2015 (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1040 Exhibit: Osborne Depo Transcript

Document IPR2019-00207, No. 1040-104 Exhibit - Osborne Depo Transcript (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1042 Exhibit: USPN 7326408

Document IPR2019-00207, No. 1042-106 Exhibit - USPN 7326408 (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1046 Exhibit: Lubrizol Dispersion Techniques

Document IPR2019-00207, No. 1046-108 Exhibit - Lubrizol Dispersion Techniques (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1050 Exhibit: Noveon

Document IPR2019-00207, No. 1050-111 Exhibit - Noveon (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 13 14 15 16 17 ... >>